These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38936059)

  • 1. Epigenetic regulation of cGAS and STING expression in cancer.
    Zhao C; Guo S; Ge S
    Int Immunopharmacol; 2024 Sep; 138():112556. PubMed ID: 38936059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer.
    Kwon J; Bakhoum SF
    Cancer Discov; 2020 Jan; 10(1):26-39. PubMed ID: 31852718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cGAS-STING Pathway: Novel Perspectives in Liver Diseases.
    Xu D; Tian Y; Xia Q; Ke B
    Front Immunol; 2021; 12():682736. PubMed ID: 33995425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cGAS-STING signaling in cancer immunity and immunotherapy.
    Du H; Xu T; Cui M
    Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cGAS/STING Pathway: A Novel Target for Cancer Therapy.
    Gan Y; Li X; Han S; Liang Q; Ma X; Rong P; Wang W; Li W
    Front Immunol; 2021; 12():795401. PubMed ID: 35046953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cGAS/STING cross-talks with cell cycle and potentiates cancer immunotherapy.
    Long ZJ; Wang JD; Xu JQ; Lei XX; Liu Q
    Mol Ther; 2022 Mar; 30(3):1006-1017. PubMed ID: 35121107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer.
    Storozynsky Q; Hitt MM
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies.
    Huang M; Cha Z; Liu R; Lin M; Gafoor NA; Kong T; Ge F; Chen W
    Front Immunol; 2024; 15():1399926. PubMed ID: 38817608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cGAS-STING pathway in cancer biotherapy.
    Wang Y; Luo J; Alu A; Han X; Wei Y; Wei X
    Mol Cancer; 2020 Sep; 19(1):136. PubMed ID: 32887628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interplay between autophagy and cGAS-STING signaling and its implications for cancer.
    Schmid M; Fischer P; Engl M; Widder J; Kerschbaum-Gruber S; Slade D
    Front Immunol; 2024; 15():1356369. PubMed ID: 38660307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cGAS-STING and Cancer: Dichotomous Roles in Tumor Immunity and Development.
    Ng KW; Marshall EA; Bell JC; Lam WL
    Trends Immunol; 2018 Jan; 39(1):44-54. PubMed ID: 28830732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy.
    Wang Y; Liu Y; Zhang J; Peng Q; Wang X; Xiao X; Shi K
    Acta Biomater; 2024 Mar; 176():51-76. PubMed ID: 38237711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.
    Anghelina D; Lam E; Falck-Pedersen E
    J Virol; 2016 Jul; 90(13):5915-27. PubMed ID: 27076643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy.
    Li A; Yi M; Qin S; Song Y; Chu Q; Wu K
    J Hematol Oncol; 2019 Apr; 12(1):35. PubMed ID: 30935414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the activation and regulation of the cGAS-STING pathway.
    Fang R; Jiang Q; Yu X; Zhao Z; Jiang Z
    Adv Immunol; 2022; 156():55-102. PubMed ID: 36410875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer immunotherapy strategies that target the cGAS-STING pathway.
    Tian Z; Zeng Y; Peng Y; Liu J; Wu F
    Front Immunol; 2022; 13():996663. PubMed ID: 36353640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer.
    Loo TM; Miyata K; Tanaka Y; Takahashi A
    Cancer Sci; 2020 Feb; 111(2):304-311. PubMed ID: 31799772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cGAS-STING at the crossroads in cancer therapy.
    Wang R; Hussain A; Guo Q; Ma M
    Crit Rev Oncol Hematol; 2024 Jan; 193():104194. PubMed ID: 37931770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanodelivery of cGAS-STING activators for tumor immunotherapy.
    Guo J; Huang L
    Trends Pharmacol Sci; 2022 Nov; 43(11):957-972. PubMed ID: 36089410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.